To estimate a realistic plant capacity for the manufacture of paracetamol from CST-derived βpinene several factors were considered. As outlined in the scope of this LCA study, the plant shall be situated in Europe for proximity to local Kraft pulping sites and the European pharmaceutical market. Based on figures published online, it was assumed that a nonintegrated chemical pulp mill in Europe manufactures 800 000 t of pulp annually, 72 and that 1 kg CST is produced per 100 kg pulp. Accordingly, it was estimated that 22 t of CST are generated per pulping site per day. Given that CST from Northern European softwood contains ~6 wt.% β-pinene (Table ), and that 38.5 wt.% of the β-pinene contained in CST can be recovered into a purified β-pinene stream (Section 3.1), it was calculated that 0.5 t/day of purified β-pinene can be obtained from the CST supply of one Kraft pulping site. As the molar yield of crude paracetamol from purified β-pinene across the novel process was calculated as 47.6 mol% (Section 3.1), it was estimated that a paracetamol output of 0.26 t/day can be obtained from a paracetamol plant supplied by one Kraft pulping site. Notably, this represents a conservative estimate that is expected to increase significantly as the processes for β-pinene purification and paracetamol manufacture are optimised through further experimental work.